AnticoagEvaluator 5.0.0.7

The AnticoagEvaluator serves as a valuable resource for healthcare professionals involved in managing non-valvular atrial fibrillation (AF) patients. Its updated features enable users to make well-informed decisions regarding antithrombotic therapy.

Key functionalities of the app include:

• Calculation of a patient's renal function and assessment of their risk for ischemic stroke, thromboembolism, and bleeding.
• Access to ACC/AHA/HRS Guideline-driven therapy guidance for effective stroke prevention.
• Generation of individualized risk assessments for various antithrombotic therapy options informed by specific clinical trials.
• Enhanced accuracy in the use of direct oral anticoagulants (DOACs) with dosage adjustments tailored to renal function and other patient-specific characteristics.

This application is built on the SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which is accessible at www.sparctool.com.